ABSTRACT
Whether for chest pain, unspecified dyspnea, or cough, chest computed tomography (CT) has become much more common in the last 10 years. The development of highresolution CT and rapid image acquisition and the publication of the National Lung Screening Trial (NLST) have only increased chest CT’s utility. Up to 25% of the chest CTs in current or former tobacco smokers will find abnormalities requiring follow-up.1 Even more, NLST showed 20% lungcancer-specific and 6.7% all-cause mortality reductions, suggesting that chest CT is likely to become even more frequent if the guidelines are implemented.1 While a large portion of these lesions will be inflammatory, infectious, granulomatous, or bronchogenic carcinomas, the burden of the pulmonologist and thorough diagnostician will be to consider and recognize less common lung tumors.
